In vivo imaging of graftversus-host disease and graftversus-leukemia - Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation - page 79

[88] Castor MG, Rezende BM, Bernardes PT, et al. PI3Kgamma controls leukocyte recruit-
ment, tissue injury, and lethality in a model of graft-versus-host disease in mice. J
Leukoc Biol 2011;89:955-64.
[89] Asaduzzaman M, Mihaescu A, Wang Y, Sato T, Thorlacius H. P-selectin and P-selectin
glycoprotein ligand 1 mediate rolling of activated CD8 + T cells in inflamed colonic
venules. J Investig Med 2009;57:765-8.
[90] Castor MG, Rezende B, Resende CB, et al. The CCL3/macrophage inflammatory
protein-1alpha-binding protein evasin-1 protects from graft-versus-host disease but
does not modify graft-versus-leukemia in mice. J Immunol 2010;184:2646-54.
[91] Wysocki CA, Panoskaltsis-Mortari A, Blazar BR, Serody JS. Leukocyte migration and
graft-versus-host disease. Blood 2005;105:4191-9.
[92] Frauenschuh A, Power CA, Deruaz M, et al. Molecular cloning and characterization of a
highly selective chemokine-binding protein from the tick Rhipicephalus sanguineus. J
Biol Chem 2007;282:27250-8.
[93] Deruaz M, Frauenschuh A, Alessandri AL, et al. Ticks produce highly selective chemo-
kine binding proteins with antiinflammatory activity. J Exp Med 2008;205:2019-31.
[94] Swallow MM, Wallin JJ, Sha WC. B7h, a novel costimulatory homolog of B7.1 and B7.2,
is induced by TNFalpha. Immunity 1999;11:423-32.
[95] Hutloff A, Dittrich AM, Beier KC, et al. ICOS is an inducible T-cell co-stimulator struc-
turally and functionally related to CD28. Nature 1999;397:263-6.
[96] Taylor PA, Panoskaltsis-Mortari A, Freeman GJ, et al. Targeting of inducible co-
stimulator (ICOS) expressed on alloreactive T cells downregulates graft-versus-host
disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM). Blood
2005;105:3372-80.
[97] Chiba K. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from
secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phos-
phate receptors. Pharmacol Ther 2005;108:308-19.
[98] Taylor PA, Ehrhardt MJ, Lees CJ, et al. Insights into the mechanism of FTY720 and com-
patibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD).
Blood 2007;110:3480-8.
[99] Taylor PA, Panoskaltsis-Mortari A, Swedin JM, et al. L-Selectin(hi) but not the L-
selectin(lo) CD4 + 25 + T-regulatory cells are potent inhibitors of GVHD and BM graft
rejection. Blood 2004;104:3804-12.
[100] Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental
biological processes in a new light. Genes Dev 2003;17:545-80.
[101] Cai W, Niu G, Chen X. Imaging of integrins as biomarkers for tumor angiogenesis. Curr
Pharm Des 2008;14:2943-73.
[102] Stelljes M, Hermann S, Albring J, et al. Clinical molecular imaging in intestinal graft-
versus-host disease: mapping of disease activity, prediction, and monitoring of treat-
ment efficiency by positron emission tomography. Blood 2008;111:2909-18.
[103] Vogelsang GB, Lee L, Bensen-Kennedy DM. Pathogenesis and treatment of graft-ver-
sus-host disease after bone marrow transplant. Annu Rev Med 2003;54:29-52.
[104] Fallows G, Rubinger M, Bernstein CN. Does gastroenterology consultation change
management of patients receiving hematopoietic stem cell transplantation? Bone Mar-
row Transplant 2001;28:289-94.
[105] Ross WA, Couriel D. Colonic graft-versus-host disease. Curr Opin Gastroenterol
2005;21:64-9.
[106] Pittet MJ, Grimm J, Berger CR, et al. In vivo imaging of T cell delivery to tumors after
adoptive transfer therapy. Proc Natl Acad Sci USA 2007;104:12457-61.
[107] Signore A, Mather SJ, Piaggio G, Malviya G, Dierckx RA. Molecular imaging of inflam-
mation/infection: nuclear medicine and optical imaging agents and methods. Chem
Rev 2010;110:3112-45.
[108] Weissleder R. Scaling down imaging: molecular mapping of cancer in mice. Nat Rev
Cancer 2002;2:11-8.
[109] Pathak AP, Gimi B, Glunde K, Ackerstaff E, Artemov D, Bhujwalla ZM. Molecular
and functional imaging of cancer: advances in MRI and MRS. Methods Enzymol
2004;386:3-60.
[110] Flint JJ, Lee CH, Hansen B, et al. Magnetic resonance microscopy of mammalian neu-
rons. Neuroimage 2009;46:1037-40.
[111] Kubo S, Levantini E, Kobayashi S, et al. Three-dimensional magnetic resonance micros-
copy of pulmonary solitary tumors in transgenic mice. Magn Reson Med 2006;56:698-
703.
[112] Long CM, Bulte JW. In vivo tracking of cellular therapeutics using magnetic resonance
imaging. Expert Opin Biol Ther 2009;9:293-306.

80